Comparison of men with impaired fasting glycaemia to controls and to diabetic subjects with fasting glycaemia from 7.0 to 7.7 mmol/l: clinical, nutritional and biological status

Diabetes & Metabolism
H CombeP Lecomte

Abstract

To compare medical history, clinical, nutritional and biological status of non-diabetic men to subjects with impaired fasting glycemia (glycemia 6.1-6.9 mmol/l) and to newly diagnosed type 2 diabetic subjects (7.0-7.7 mmol/l) according to the criteria proposed by the American Diabetes Association. Cross-sectional study of a cohort of 29,992 men, who were volunteers for a free periodic check-up offered by their medical insurance. Medical history, lifestyle and nutritional habits were recorded using a self-administered questionnaire. Clinical and biological data were also studied. To compare the three groups of subjects - normal, impaired fasting glycemia and newly diagnosed diabetics - three age stratified samples were randomly designed. Most of the well-known risk factors for developing type 2 diabetes mellitus such as overweight, abdominal obesity, familial history of diabetes mellitus, over-consumption of fat and alcohol were present in the group with impaired fasting glycaemia which presented the same risk factors as the group of subjects with fasting glycaemia from 7.0 to 7.7 mmol/l, but to a lesser degree. Hypertension was present in more than 50% of the subjects with impaired fasting glycaemia. In this cross-sectional stu...Continue Reading

References

Jul 1, 1992·Diabetes Care·M I HarrisM W Knuiman
Dec 1, 1994·Journal of Epidemiology and Community Health·I J PerryA G Shaper
Dec 14, 1996·Lancet·M A CharlesE Eschwège
Apr 1, 1997·Diabetes Care·J SalmerónW C Willett
Jan 7, 1999·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·J DallongevilleP Amouyel
May 20, 1999·Diabetes Care·A L RosenbloomW E Winter
Nov 18, 2000·Proceedings of the Society for Experimental Biology and Medicine·L C Hudgins
May 3, 2001·The New England Journal of Medicine·J TuomilehtoUNKNOWN Finnish Diabetes Prevention Study Group
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Jul 30, 2002·Diabetes·Anthony J G HanleyUNKNOWN Insulin Resistance Atherosclerosis Study
Oct 16, 2002·Current Cardiology Reports·John E Hokanson

❮ Previous
Next ❯

Citations

Dec 17, 2004·Obesity Research·Jesse RothBarbara C Lowell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.